Nivolumab versus investigator’s choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age
暂无分享,去创建一个
K. Harrington | R. Ferris | P. Brossart | L. Licitra | M. Gillison | N. Saba | J. Fayette | G. Blumenschein | V. Jayaprakash | N. Kiyota | J. Guigay | Li Li